Bisperoxovanadium, a phospho-tyrosine phosphatase inhibitor, reprograms myogenic cells to acquire a pluripotent, circulating phenotype FASEB J. Castaldi et al.
21: 3573
Supplemental Data
Files in this Data Supplement:
Figure S1 -
(06-7454FigureS1.pdf; 75 KB) The ΔSP mutant functions as a dominant negative for NFκB dependent transcription in C2C12 cells.
